CastleArk Management »

Crinetics Pharmaceuticals In shares owned by CastleArk Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by CastleArk Management from 13F filings

Historical chart of CastleArk Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by CastleArk Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.0M 78k 51.13
2024-09-30 $3.7M 73k 51.10

More positions owned by CastleArk Management

Advisors Inner Circle Fd Ii Castleark Large (CARK)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Spdr Series Trust Portfolio Intrmd (SPIB)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Us Treas Bd Etf (GOVT)
Broadcom (AVGO)
Lam Research Corp Com New (LRCX)
Netflix (NFLX)
Arista Networks Com Shs (ANET)
Charles Schwab Corporation (SCHW)

View all positions for CastleArk Management

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Driehaus Capital Management
Farallon Capital Management
EcoR1 Capital
Henderson Group
Paradigm Biocapital Advisors
Geode Capital Management
State Street Corporation
Jennison Associates
Point72 Asset Management
Siren
Novo A/S

View all funds holding Crinetics Pharmaceuticals In